{"url_path":"/sec/xbio/8-k/2026-05-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1534525/0001683168-26-003766-index.html","accession_number":"0001683168-26-003766","cik":"0001534525","ticker":"XBIO","issuer_name":"Xenetic Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1534525/0001683168-26-003766-index.html","primary_entity_key":"0001534525","primary_entity_name":"Xenetic Biosciences, Inc."},"word_count":423,"has_tables":true,"body_markdown":"**Item 2.02.**\n**Results of Operations and Financial Condition.**\n\n \n\nOn May 13, 2026, Xenetic Biosciences, Inc. (the\n“Company”) issued a press release announcing results for the three months ended March 31, 2026.\n\n \n\nThe full text of the press release is furnished\nas Exhibit 99.1 to this Current Report on Form 8-K and hereby incorporated in this Item 2.02 by reference. The information in this Item\n2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange\nAct of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended,\nexcept as shall be expressly set forth by specific reference in such filing.\n\n \n\n**FORWARD-LOOKING STATEMENTS**\n\n \n\nThis Form 8-K, including the press release, contains\nforward-looking statements that we intend to be subject to the safe harbor provisions of the Private Securities Litigation Reform Act\nof 1995. All statements contained in this Form 8-K, including the press release, other than statements of historical facts may constitute\nforward-looking statements within the meaning of the federal securities laws. These statements can be identified by words such as “expects,”\n“plans,” “projects,” “will,” “may,” “anticipates,” “believes,”\n“should,” “intends,” “estimates,” and other words of similar meaning. Any forward-looking statements\ncontained herein are based on current expectations, and are subject to a number of risks and uncertainties. Many factors could cause our\nactual activities, performance, achievements or results to differ materially from the activities and results anticipated in forward-looking\nstatements. These risks and uncertainties include those described in the “Risk Factors” section as detailed from time to time\nin the Company’s reports filed with the Securities and Exchange Commission (“SEC”), including the Company’s annual\nreport on Form 10-K, periodic quarterly reports on Form 10-Q, current reports on Form 8-K and other documents filed with the SEC. In addition,\nforward-looking statements may also be adversely affected by general market factors, general economic and business conditions, including\npotential adverse effects of public health issues and geopolitical events, such as the conflicts in the Ukraine and in the Middle East,\non economic activity, competitive product development, product availability, federal and state regulations and legislation, the regulatory\nprocess for new product candidates and indications, manufacturing issues that may arise, patent positions, litigation, and shareholder\nactivism, among other factors. The forward-looking statements contained in this Form 8-K, including the press release, speak only as of\nthe date the statements were made, and the Company does not undertake any obligation to update forward-looking statements, except as required\nby law."}